tafluprost



tafluprost


SMILES CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(F)(F)COc2ccccc2)[C@H](O)C[C@@H]1O
InChIKey WSNODXPBBALQOF-VEJSHDCNSA-N

Chemical Properties

Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 12
Molecular weight (Da) 452.2


No bioactivity data available.

tafluprost


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV


Compound is not listed as a drug.